Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ATIC mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ATIC mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of ATIC mRNA | affects expression | 21346803
|
C000188 |
alachlor |
alachlor results in increased expression of ATIC mRNA | increases expression | 12419858
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ATIC mRNA | affects expression | 16483693
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of ATIC mRNA | increases expression | 17484886
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATIC mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATIC mRNA | affects cotreatment|affects expression | 17602206
|
D008727 |
Methotrexate |
ATIC gene SNP affects the susceptibility to Methotrexate | affects response to substance | 17410198
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of ATIC mRNA | increases expression | 17616710
|
C010327 |
salinomycin |
salinomycin results in decreased expression of ATIC mRNA | decreases expression | 19682730
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ATIC protein | decreases expression | 19201780
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of ATIC mRNA | decreases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
21.43 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
21.43 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
21.43 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
21.43 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.01 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.89 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.45 | 17620307 19052882 19061943 17162532 16434500 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.45 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
alachlor |
4.77 | 14769641 11874814 |
OMIM:608688 |
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY |
marker/mechanism |
|
| |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.37 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.64 | 17497229 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.11 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 20603192 19232924 15238991 18396377 17507914 18558336 18316065 18177632 17688650 18775368 17157402 19460635 18985861 16609825 18940202 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.11 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.19 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.19 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.04 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.04 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
2.04 | 19682730 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.04 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.88 | 10355542 15673190 16124888 16227642 16097048 15700767 18705752 16192424 16011737 15721981 16050911 3786805 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.67 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.67 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.67 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.67 | 17162532 20727157 19519916 16935385 20935162 18210153 20101231 17761372 18494052 19822196 16830150 3084413 17428255 17173139 16540662 18393292 20512989 20524982 16807293 20007298 18978308 19052882 18785209 16569478 3581430 17978847 19335982 20214788 19107877 16328049 19394651 21159647 19383236 19701751 20084675 17138121 16698587 18506893 10737359 16288022 16681979 19539802 19418558 16779866 10672840 11831363 19208518 19171122 16878318 16502159 20432363 18971187 17055752 18665156 18788625 20514400 18056438 18691550 19919837 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18670907 16120746 18850075 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.67 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.88 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
6.88 | 2727394 7505956 17174075 21159647 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.73 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.57 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.57 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 15668235 15340226 12621046 16354765 8697196 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
9.43 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.43 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.92 | 12039119 9562676 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.92 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.92 | 17688650 8888407 16575769 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.25 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.25 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.31 | 19747007 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
alachlor |
4.29 | 8428444 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.22 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.28 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.28 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
19.07 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
19.07 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
19.07 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
19.07 | 3732212 17522070 15968718 16177239 9327722 7440962 19336974 4309450 11566570 16227642 10092053 19085960 7179309 2869522 7120509 3786805 15998439 6884620 10915739 15027814 6623471 21278145 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
19.07 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
19.07 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
19.07 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.14 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.46 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 16714409 15322242 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.26 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.05 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.97 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.66 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.40 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.18 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.25 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
2.79 | 15547733 15150132 16805852 15547721 15878914 15623463 15264214 16510608 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
13.65 | 15959796 17595544 16239168 19224547 12631006 12795759 16045604 61145 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
13.65 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.65 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.02 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.23 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.95 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.25 | 16518429 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.69 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 12621046 15340226 16120746 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.98 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 18606429 16354765 8697196 16959395 15340226 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.65 | 16899240 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.93 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.19 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
alachlor |
4.19 | 16466525 12948887 17049205 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.03 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.03 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.59 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.59 | 16705839 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.19 | 9562676 |
MESH:D007938 |
Leukemia |
|
alachlor |
4.05 | 14769641 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.16 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
11.38 | 16239168 11903743 17174718 17157831 21278145 16221502 17334410 16943688 11408273 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
11.38 | 19638242 18522880 18407596 20032147 18665156 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
11.38 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.31 | 17714472 12632512 18420326 17557913 15370692 15338365 16011737 12546737 12609069 15876570 18277467 17640975 18376398 13678700 16638106 17708605 14512876 12445421 17869086 15818738 15931870 18395914 18251166 12632514 14716833 15730626 12649538 18412020 14748882 18187930 15925388 15673190 14620537 12898905 18263696 17631135 16097048 16192424 16033810 17525996 17823541 18210741 17922224 12667390 18395095 18156304 17481882 17766677 17976157 17805973 18472094 18418968 18006644 16248980 17900296 17761835 16136751 18205269 18054572 17944888 12666154 18317297 12389079 10355542 17698563 14724832 14716496 16027843 15052691 15650968 18472332 12958196 12445418 15893842 16015684 15996030 15959796 20821823 12741479 11481614 15362042 18279442 18339082 12586293 15123356 17721639 18481824 18166357 17565644 16116963 18429990 18705752 15057751 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.31 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
4.13 | 16246199 16964402 15830285 15720792 17285989 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.13 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.27 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.77 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.56 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
14.56 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
14.56 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
14.56 | 21071580 20405173 19642983 15885732 19090486 20583210 19551842 19256749 20118626 19255062 15175105 19833225 18648771 9163691 2862719 19996281 20501860 21167192 19254457 20434301 2422723 21047994 18978307 19850985 19073162 20492335 19499222 10737359 20137499 19427195 12771043 18644402 16942905 18754104 12112319 18977376 19690152 19426721 19638242 20101389 19294768 21278145 19812893 20452335 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.56 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.52 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
14.52 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
14.52 | 18253720 18282651 18544905 18093689 19126423 18308698 18164116 19519916 18775883 16842330 18079962 17854601 19539802 3124819 19009564 17942915 2563599 21159647 17174075 19004024 16267830 9362446 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.52 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
11.92 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
11.92 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.28 | 6695378 21163286 20512841 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.28 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.01 | 17352296 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
3.81 | 19682730 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.25 | 18765137 18803445 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.40 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
alachlor |
4.34 | 14769641 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.11 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.20 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.74 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.74 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.59 | 9029167 3581430 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.18 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.41 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.25 | 20387270 |
MESH:D009669 |
Nose Neoplasms |
|
alachlor |
4.94 | 14563481 11127290 16178123 15580706 16698726 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
15.61 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
15.61 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
15.61 | 14694615 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.45 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.62 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.86 | 11118676 11399792 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.86 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.67 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.46 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.82 | 17352296 |
MESH:D012135 |
Respiratory Sounds |
|
alachlor |
5.05 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.26 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.14 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.14 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
10.14 | 14763951 16876388 1511512 17978042 11738929 11044598 15475178 3137016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.08 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.84 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.67 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.63 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.63 | 12958204 17575124 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.13 | 9562676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
alachlor |
7.84 | 8812207 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.84 | 7505956 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.37 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.64 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.11 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.11 | 16049721 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.75 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.39 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.39 | 10091137 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |